Cynthia Trickett, MPAS, PA-C, and Leigh Ann Pansch, MSN, FNP-BC, DCNP, discussed recognizing hidradenitis suppurativa early, screening for comorbidities, and assessing disease burden.
Leigh Ann Pansch, MSN, FNP-BC, DCNP
Advertisement
Leigh Ann Pansch, MSN, FNP-C, DCN, is a nurse practitioner and the clinical director of education at DOCS Dermatology in Cincinnati, Ohio.
Articles by Leigh Ann Pansch, MSN, FNP-BC, DCNP
Discover the latest advancements in pediatric dermatology and atopic dermatitis treatments from Maui Derm NP+PA Fall 2025, featuring expert insights and emerging therapies.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
EADV 2026 Day 1: Late-Breaking Data, Emerging Therapies, and New Directions in Dermatology
2
EADV 2026 Day 2: Long-Term AD Data, GLP-1 Nail Findings, and Emerging Treatments Take Center Stage
3
Tulisokibart Meets Primary Endpoint in Phase 2b Hidradenitis Suppurativa Trial
4
Repigmentation With Upadacitinib Continues Through Week 76 in Non-Segmental Vitiligo
5